However, this blood supply also lends itself to increased swelling and the risk of bruising
A randomized, placebo-controlled trial published in Diabetes, Obesity and Metabolism found that semaglutide led to a 24% reduction in total daily energy intake compared to placebo, driven primarily by reduced appetite and fewer food cravings rather than nausea or food aversion
For most people using GLP-1 receptor agonists, the findings do not warrant stopping treatment
Additionally, if itching is severe enough to disrupt sleep, daily activities, or quality of life, or if it is associated with skin changes such as blistering, peeling, or significant inflammation, medical review is advisable
These studies aim to establish efficacy, optimal dosing, treatment duration, and patient selection criteria
It depends on the concentration of the liquid medicine in your specific vial